Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare Biotechnology
Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma Announces the Inauguration of Its Drug Development Lab at Biohouse in the Hadassah Medical Center in Jerusalem

Newsfile January 17, 2022

InnoCan Pharma (CSE:INNO) expands CBD research into veterinary field

Trevor Abes  January 13, 2022

Innocan Pharma to Expand its LPT Platform to the Veterinary Field

Newsfile January 13, 2022

Innocan Announces the Execution of a Research & License Agreement with Ramot, the Technology Transfer Company of the Tel Aviv University for Cannabinoids Loaded Exosome Delivery Platform (CLX)

Newsfile December 9, 2021

Innocan Pharma Announces the Successful Demonstration of Prolonged Release of CDB in Dogs Using Its LPT Technology

Newsfile November 18, 2021

Innocan Pharma to Participate in the Lift & Co. Expo's Business Growth Panel on November 19th, 2021

Newsfile November 15, 2021

Innocan Pharma Reports Further Success in Profile Characterization Progress In Its micro-RNA Cannabinoids Loaded Exosome Delivery Platform (CLX) Project

Newsfile November 10, 2021

Innocan Pharma (CSE:INNO) announces full exercise of warrants

John Ballem  November 5, 2021

Innocan Pharma Announces 100% Exercise of Warrants Issued in December 2020 Private Placement

Newsfile November 5, 2021

Innocan Pharma CEO Iris Bincovich to Deliver a Speech at an Investor Gathering in Munich on October 29, 2021

Newsfile October 28, 2021

Innocan Pharma (CSE:INNO) reports CBD in mice’s brains 41 days after injection

Caroline Egan  October 19, 2021

Innocan Reports of Presence of CBD in Mice's Brains 41 Days After Injection of CBD Using Innocan's Liposome Platform Technology

Newsfile October 19, 2021

Innocan Pharma Corporation Closes C$8.2 Million Private Placement with Institutional Investors

Newsfile October 13, 2021

Innocan Pharma Corporation (CSE:INNO) announces $8.2 million private placement with investors

Caroline Egan  October 8, 2021

Innocan Pharma Corporation Announces C$8.2 Million Private Placement with Institutional Investors

Newsfile October 8, 2021

Innocan Pharma Announces the Filing of a PCT Patent Application for its CBD Delivery System Technology in 153 Countries

Newsfile October 4, 2021

Innocan Pharma Announces the Filing by Ramot at Tel Aviv University of an International Patent Application for its Unique Cannabinoids Loaded Exosome Delivery Platform (CLX)

Newsfile September 24, 2021

Cannabis Industry Investor Presentations Now Available for On-Demand Viewing

PR Newswire September 13, 2021

Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals

Newsfile September 3, 2021

Cannabis Executives Present: Cannabis Investor Conference September 8th & 9th

PR Newswire September 3, 2021